ORIGINAL ARTICLE

UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome

L Haines¹, A R Fielder², H Baker¹ and A R Wilkinson³

¹ Royal College of Paediatrics and Child Health, London, UK
² Department of Ophthalmology, Imperial College London, UK
³ Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK

Correspondence to:
Correspondence to:
Professor Wilkinson
Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; andrew.wilkinson{at}paediatrics.ox.ac.uk

Background: Retinopathy of prematurity (ROP) is one of the few causes of childhood blindness in which severe vision impairment is largely preventable. Ophthalmic screening for ROP is required to identify disease that requires treatment whereby the development of potentially blinding disease can be minimised.

Objectives: To make the first UK population based estimate of the incidence of babies with severe ROP (stage 3 or more); to document their clinical characteristics and management and to evaluate the appropriateness of current ROP screening guidelines in the UK.

Patients: Cases were recruited through a national surveillance programme with 1 year ophthalmic follow up and data from clinician completed questionnaires.

Results: Between 1 December 1997 and 31 March 1999, 233 preterm babies with stage 3 ROP were identified. Severity (location, extent, and presence of plus disease) was associated with degree of prematurity, most severe in the most premature babies. Fifty nine percent were treated. The UK screening protocol was followed in two thirds of cases, but in the remainder it was begun too late or was too infrequent. Three quarters of the cases were followed up at 1 year, and 13% had a severe vision deficit as a result of ROP.

Conclusions: Visual deficit as a result of ROP in premature babies continues to be a severe disability in some of the survivors of neonatal intensive care. Further efforts are needed to organise treatment regionally to improve outcome and standards of practice.

Keywords: retinopathy of prematurity; screening

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Fantoms

Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2005 90: F189. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Hvidtjorn, D., Schieve, L., Schendel, D., Jacobsson, B., Svaerke, C., Thorsen, P. (2009). Cerebral Palsy, Autism Spectrum Disorders, and Developmental Delay in Children Born After Assisted Conception: A Systematic Review and Meta-analysis. Arch Pediatr Adolesc Med 163: 72-83 [Abstract] [Full Text]  
• Varughese, S, Gilbert, C, Pieper, C, Cook, C (2008). Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes. Br. J. Ophthalmol. 92: 879-882 [Abstract] [Full Text]  
• Todd, D A, Wright, A, Smith, J, the NICUS Group, (2007). Severe retinopathy of prematurity in infants <30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002. Arch. Dis. Child. Fetal Neonatal Ed. 92: F251-F254 [Abstract] [Full Text]  
• Msall, M. E. (2006). The retina as a window to the brain in vulnerable neonates.. Pediatrics 117: 2287-2289 [Full Text]  
• (2005). ROP claims sight needlessly. Br. J. Ophthalmol. 89: 1096-1096 [Full Text]  

eLetters:

Read all eLetters

Avoiding ROP blindness

Padmaja Kumari Rani, et al.

Fetal Neonatal Ed. Online, 25 Aug 2005 [Full text]

Re: Avoiding ROP blindness

Kanchan Majumdar

Fetal Neonatal Ed. Online, 31 Aug 2005 [Full text]